|Packaging Size||4000 IU|
|Composition||Recombinant Human IP 4000 IU|
|Shelf life||As Per Expiry Date|
|Service Location City||Pan India|
Renocrit 4000 IU Injection is a medication classified as an erythropoiesis-stimulating agent (ESA) used to treat anemia, particularly in patients with chronic kidney disease (CKD) or those undergoing certain medical treatments. The active ingredient in Renocrit is epoetin beta, a synthetic form of erythropoietin—a hormone naturally produced by the kidneys that stimulates the production of red blood cells in the bone marrow.
Mechanism of Action: Epoetin beta in Renocrit works by mimicking the action of endogenous erythropoietin. It binds to specific receptors on the surface of bone marrow cells, stimulating their differentiation and maturation into red blood cells. As a result, the medication helps to increase the production of red blood cells, thus correcting anemia and improving the oxygen-carrying capacity of the blood.
|Packaging Size||5 ml|
|Drug Type||Anticoagulant Drug|
|Prescription/ Non Prescription||Prescription|
|Shelf Life||As Per Expiry Date|
Heparin injection is a widely used anticoagulant medication that plays a crucial role in preventing and treating blood clotting disorders. It belongs to a class of drugs known as heparins, which are derived from porcine intestinal mucosa or bovine lung tissue. Mechanism of Action: Heparin exerts its anticoagulant effects by enhancing the activity of antithrombin III, a natural substance in the blood that inhibits clotting factors. By accelerating the action of antithrombin III, heparin prevents the formation and growth of blood clots, reducing the risk of complications associated with excessive clotting, such as deep vein thrombosis (DVT), pulmonary embolism (PE), and strokes caused by blood clots.
|Minimum Order Quantity||3 Box|
|Brand||CRESP 100 mcg|
|Storage Temperature||2-8 Degree|
|Shelf life||3 yr|
|Country of Origin||Made in India|
|Usage||For I.V Use Only|
|Dose||20 mg / Vial|
|Composition||Daunorubicin Hydrochloride IP 20 mg|
|Treatment||For Cancer Treatment|
|Full Name||Daunorubitec Lyophilized|
Daunorubicin Hydrochloride Injection is a potent chemotherapy medication used in the treatment of certain types of cancer. It belongs to the class of drugs known as anthracyclines, which are highly effective in combating various malignancies. The injection contains Daunorubicin Hydrochloride as the active ingredient and is formulated to slow down or inhibit the growth and spread of cancer cells in the body.
Daunorubicin Hydrochloride Injection is primarily indicated for the treatment of various types of leukemia, including acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and certain forms of chronic myeloid leukemia (CML). It is also used in the treatment of other types of cancer, such as certain types of lymphoma and solid tumors, depending on the specific treatment protocols.
Mode of Action:
Daunorubicin Hydrochloride works by interfering with the DNA and RNA synthesis in cancer cells. It exerts its cytotoxic effects by inhibiting the action of an enzyme called topoisomerase II, which is essential for DNA replication and repair. By disrupting these processes, the drug hinders the cancer cells' ability to proliferate and survive, leading to their death.
Dosage and Administration:
The dosage of Daunorubicin Hydrochloride Injection is determined by the treating oncologist and is based on factors such as the patient's body weight, overall health status, and the type and stage of cancer being treated. It is typically administered intravenously (IV) in a hospital or clinical setting by healthcare professionals experienced in chemotherapy administration.